Fundamentals of Options Seminar, Mar. 10, 2023
During our last info sessions in Sep. 2020, I personally enjoyed audience contributions and good questions. We had a great...
Derivatix Quarterly Report: 2022-Q4 as of Dec. 31, 2022
2022-Q4 Market Summary*: Markets and economists focused on inflation for much of 2022. Most central banks continued raising interest rates aggressively to slow the...
Derivatix Quarterly Report: 2022-Q2 as of Sep. 30th, 2022
2022-Q3 Market Summary*: The S&P 500 decreased by -5.3% in the third quarter bringing the year-to-date decline to -24.8%. Through...
Derivatix Quarterly Report: 2022-Q2 as of Jun. 30th, 2022
Summer is here ladies and gentlemen. Enjoy it before it goes fast…. 2022-Q2 Market Summary*: Recession fears and an...
Derivatix Quarterly Report: 2022-Q1 as of Mar. 31st, 2022
Happy spring to all who have been waiting long for outdoor activities…. 2022-Q1 Market Summary*: U.S. equities closed out their...
Derivatix Quarterly Report: 2021-Q4 as of Dec. 31st, 2021
2021-Q4 Market Summary*: It was a wild year in many respects, but the stock market turned in a solid performance...
Derivatix Quarterly Report: 2021-Q2 as of Sep. 30th, 2021
As we are getting more and more into the beautiful fall, we would like to take this opportunity to wish...
Derivatix Quarterly Report: 2021-Q2 as of Jun. 30th, 2021
2021-Q2 Market Summary*: U.S. equity benchmarks closed the first half of 2021 at or near record highs as the economy...
Derivatix Quarterly Report: 2021-Q1 as of Mar. 30th, 2021
2020-Q4 Market Summary*: Efficient U.S. vaccination distribution, $1.9 trillion in fiscal stimulus, and a proposed $2 trillion infrastructure bill are...
Derivatix Quarterly Report: Mid 2021-Q1 as of Feb. 16th 2021
2021-Q1 Market Summary*: U.S. equities reversed losses and staged a rally as Federal Reserve Chairman Jerome Powell reaffirmed his view...
Recent Comments